Development of an all-in-one lentiviral vector that enhances the antitumor effect of CAR-T cells and reduces the risk of CRS and ICANS

Izumi Maki

Presentation information

Oral Session

[O5] Oral Session 5"Viral vectors 2"

Tue. Sep 12, 2023 9:00 AM - 10:10 AM Room 3 (1008, 10Ｆ, OICC)

Chairs:Ken-ichiro Kosai（Department of Gene Therapy and Regenerative Medicine. Kagoshima University Graduate School of Medical and Dental Sciences. ）,Hiroaki MIZUKAMI（Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical University）

[O5-1] Development of an all-in-one lentiviral vector that enhances the antitumor effect of CAR-T cells and reduces the risk of CRS and ICANS

^○Izumi Maki¹, Y. Amaishi¹, Seina Inui¹, Ryousuke Nagata¹, Toshiaki Yoshikawa², Yuki Kagoya², Sachiko Okamoto¹, Ryuji Enoki¹ (1.Technology Development Center, Takara Bio Inc., 2.Division of Tumor Immunology, Institute for Advanced Medical Research, Keio University School of Medicine)

Abstract password authentication.
The password was sent to all registrants in email.

Presentation information

[O5] Oral Session 5"Viral vectors 2"

[O5-1] Development of an all-in-one lentiviral vector that enhances the antitumor effect of CAR-T cells and reduces the risk of CRS and ICANS

Password